Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EMJ Hematology 11.1 2023
July 2023
We are delighted to present the latest issue of EMJ Hematology! This issue features a review of the scientific highlights from this year’s…
Read more
March 2024
EMJ Hematology 12 [Supplement 1] 2024
Welcome to our supplement providing an excellent review of the European Association for Haemophilia and Allied Disorders (EAHAD)…
January 2024
EMJ Cardiology 12 [Supplement 1] 2024
The AZALEA-TIMI 71 trial is the first study to provide definitive evidence that factor XI inhibition substantially reduces bleeding…
December 2023
EMJ Hematology 11 [Supplement 5] 2023
Pyruvate kinase (PK) deficiency is a rare genetic disorder causing non-spherocytic haemolytic anaemia due to impaired adenosine…
August 2023
EMJ Hematology 11 [Supplement 4] 2023
The thalassaemias are a heterogenous group of inherited blood disorders with the commonality of impaired haemoglobin synthesis, resulting…
August 2023
EMJ Hematology 11 [Supplement 3] 2023
This article highlights key insights from a symposium on treatment options for patients with relapsed/refractory diffuse large B cell…
July 2023
EMJ Hematology 11.1 2023
We are delighted to present the latest issue of EMJ Hematology! This issue features a review of the scientific highlights from this year’s…
February 2023
EMJ Hematology 11 [Supplement 1] 2023
Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.
September 2022
EMJ Hematology 10 [Supplement 5] 2022
This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022.
Loading posts...
1
2
3
…
6
Next »